Trials / Completed
CompletedNCT00002377
A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the efficacy and safety of RS-79070 when used as induction therapy in patients with newly diagnosed peripheral retinitis. To assess the effects of induction and maintenance level dosing of RS-79070 on CMV viral load, estimated by plasma CMV PCR. To assess the pharmacokinetics of ganciclovir following administration of RS-79070 in the target population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Valganciclovir | |
| DRUG | Ganciclovir |
Timeline
- Start date
- 1997-01-01
- Primary completion
- 2002-12-01
- Completion
- 2002-12-01
- First posted
- 2001-08-31
- Last updated
- 2017-05-17
Locations
19 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00002377. Inclusion in this directory is not an endorsement.